Clinical Trial Update: Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Faso [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the safety and efficacy of methylene blue combined with amodiaquine or artesunate for treating malaria in children in Burkina Faso.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Artesunate (artesunate)
• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Heidelberg University | Conditions: Malaria | Phase 2 | Status: COMPLETED